Brief: Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO
09/12/2021 14:18
Dec 9 (Reuters) - Genetic Technologies Ltd GTG.AX :
* GENETIC TECHNOLOGIES ANNOUNCES NEW PARTNERSHIP AND
GENETYPE
COVID-19 RISK TEST PATENT ALLOWANCE FROM THE USPTO
* GENETIC TECHNOLOGIES LTD - NEW PARTNERSHIP AGREEMENT
SIGNED WITH
IBX AND 1HEALTH
Source text for Eikon: ID:nGNX5yc88r
Further company coverage: GTG.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Genetic Technologies
See all newsBrief: ASX Says Genetic Technologies To Be Removed From Official List
Brief: Genetic Technologies Announces Termination Of ADR Facility
Brief: Genetic Technologies To Not Proceed With Ellerfield Wealth Acquisition
Brief: Genetic Technologies Says Binding Term Sheets Executed For Strategic Acquisitions
Brief: Genetic Technologies Appointed Michael Walker As Executive Chairman